1Wüllner U,Schmitz Hübsch T,Abele M,et al.Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson's disease[J].J Neural Transm,2007,114(9):1161-1165.
2Yabe I,Soma H,Takei A,et al.MSA C is the predominant clinical phenotype of MSA in Japan:analysis of 142 patients with probable MSA[J].J Neurol Sci,2006,249(2):115-121.
3Kao AW,Racine CA,Quitania LC,et al.Cognitive and neuropsychiatric profile of the synucleinopathies:Parkinson disease,dementia with lewy bodies,and multiple system atrophy[J].Alzheimer Dis Assoc Disord,2009,23(4):365-370.
4Chang CC,Chang YY,Chang WN,et al.Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration[J].Eur J Neurol,2009,16(10):1144-1150.
5Gilman S,Wenning GK,Low PA,et al.Second consensus statement on the diagnosis of multiple system atrophy[J].Neurology,2008,71(9):670-676.
6Chang MH,Hung WL,Liao YC,et al.Eye of the tiger-like MRI in parkinsonian variant of multiple system atrope[J].J Neural Transm,2009,116(7):861-866.
7Hauser TK,Luft A,Skalej M,et al.Visualization and quantification of disease progression in multiple system atrophy[J].Mov Disord,2006,21(10):1674-1681.
9Benarroch EE,Schmeichel AM,Dugger BN,et al.Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia[J].Neurology,2009,73(2):106-112.
10Sone M,Yoshida M,Hashizume Y,et al.alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy[J].Acta Neuropathol,2005,110(1):19-26.
